Evidence map›Paper›PMID 28343350›Full record

ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2017

An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D.

Yan Feng, Mike Herdman, Floortje van Nooten, Charles Cleeland, David Parkin, Shunya Ikeda, Ataru Igarashi, Nancy J Devlin

Open access · hybridAbstract read
In one paragraph

Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Psychometric properties of the EQ-5D-5L: a systematic review of the literature.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Pooled it
  2. Pooled it
  3. Minimal important differences of EORTC QLQ-C30 for metastatic breast cancer patients: Results from a randomized clinical trial.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2022
    Trial
  4. Article
  5. Review
  6. Time perspective profile and self-reported health on the EQ-5D.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. How is quality of life defined and assessed in published research?Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Review
  11. Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Article
  12. Article
  13. Article
  14. Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged "no-problems".Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2020
    Observational
  15. Article
  16. A comparison of self-rated health using EQ-5D VAS in the United States in 2002 and 2017.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2019
    Article
  17. Article
  18. Health utility and health-related quality of life of Japanese prostate cancer patients according to progression status measured using EQ-5D-5L and FACT-P.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Yan FengOffice of Health Economics, London, UK. yfeng@ohe.org.
Mike HerdmanOffice of Health Economics, London, UK.
Floortje van NootenFormerly with Astellas Pharma BV, Leiden, The Netherlands.
Charles CleelandMD Anderson Cancer Center, Houston, TX, USA.
David ParkinOffice of Health Economics, London, UK.
Shunya IkedaInternational University of Health and Welfare, Otawara, Japan.
Ataru IgarashiUniversity of Tokyo, Tokyo, Japan.
Nancy J DevlinOffice of Health Economics, London, UK.
Office Of Health Economics · GBAstellas Pharma (Netherlands) · NLInternational University of Health and Welfare · JPThe University of Texas MD Anderson Cancer Center · USThe University of Tokyo · JP

Funding

Wellcome Trust
6 · The paper itself

Abstract

purposeTo investigate the systematic differences in the self-reporting and valuation of overall health and, in particular, pain/discomfort between three countries (England/UK, Japan, and Spain) on the EQ-5D.

methodsExisting datasets were used to explore differences in responses on the EQ-5D descriptive system between Japan (3L and 5L), the UK (3L), England (5L), and Spain (5L), particularly on the dimension of pain/discomfort. The role of different EQ dimensions in determining self-reported overall health scores for the EuroQol visual analog scale (EQ-VAS) was investigated using ordinary least squares regression. Time trade-off (TTO) results from Japanese and UK respondents for the EQ-5D-3L as well as Japanese and English respondents for the EQ-5D-5L were compared using t tests.

resultsFor the EQ-5D-3L, a higher percentage of respondents in Japan than in the UK reported 'no pain/discomfort' (81.6 vs 67.0%, respectively); for the EQ-5D-5L, the proportions were 79.2% in Spain, 73.2% in Japan, and 63-64% in England, after adjusting for age differences in samples. The 'pain/discomfort' dimension had the largest impact on respondents' self-reported EQ-VAS only for EQ-5D-3L in Japan. Using the EQ-5D-3L, Japanese respondents were considerably less willing to trade off time to avoid pain/discomfort than the UK respondents; for example, moving from health state, 11121 (some problems with pain/discomfort) to 11131 (extreme pain/discomfort) represented a decrement of 0.65 on the observed TTO value in the UK compared with 0.15 in Japan. Using the EQ-5D-5L, Japanese respondents were also less willing to trade off time to avoid pain/discomfort than respondents in England; however, the difference in values was much smaller than that observed using EQ-5D-3L data.

conclusionsThis study provides evidence of between-country differences in the self-reporting and valuation of health, including pain/discomfort, when using EQ-5D in general population samples. The results suggest a need for caution when comparing or aggregating EQ-5D self-reported data in multi-country studies.

Indexed as

Health StatusPatient Reported Outcome MeasuresEuropeFemaleHumansJapanMaleMiddle AgedPain MeasurementQuality of LifeSelf ReportSurveys and QuestionnairesBetween-country comparisonEQ-5DHealth state valuationPatient-reported outcomesSelf-reported pain/discomfort

Identifiers

PMID28343350
PMCPMC5509839
OpenAlexW2598909723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.